Developments in anti-malaria agents: chemical data, structure-activity relationships
Debaert, M.
Annales Pharmaceutiques Francaises 59(2): 75-84
2001
ISSN/ISBN: 0003-4509 PMID: 11320331 Document Number: 536152
Various features of the evolution of a few antimalarial drugs including amodiaquine, dihydrofolate-reductase inhibitors, and artemisinin are described. The mechanism of action of artemisinin is detailed to explain the information of the main metabolites and drug design of certain compounds. Structure-activity and structure-neurotoxicity relations are reported. A few examples of cyclic peroxycetal synthesis are given. Finally, trends in new and novel compounds are presented.
Document emailed within 1 workday
Related Documents
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542Waisser, K.; Dolezal, M.; Sidóová, E.; Odlerová, Z.; Drsata, J. 1988: Biological side-effects of potential anti-tubercular agents. XIV. Relation between the chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-(2-chlorobenzamido) benzothiazoles Ceskoslovenska Farmacie 37(10): 437-439
Menkes, B.; Vîlceanu, R.; Neda, I.; Prelipceanu, O.; Checiu, I.; Gârban, Z. 1980: Vital fluorochrome staining as a means of studying the relationships between chemical structure and the cytotoxic effect of some alkylating agents Morphologie et Embryologie 26(2): 119-123
Rejholec, V.; Kuchar, M. 1980: Use of methods of differentiating between arrangements in chemical structure and biological activity relationships Ceskoslovenska Farmacie 29(8-9): 315-320
Rey, A. 1974: Cholinergic and anticholinergic agents. Structure-activity relationships. II. Benzilates Il Farmaco; Edizione Scientifica 29(4): 281-293
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677
Atherton, F.R.; Hall, M.J.; Hassall, C.H.; Lambert, R.W.; Ringrose, P.S. 1979: Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships Antimicrobial Agents and Chemotherapy 15(5): 677-683
Kojima, E.; Shirasaka, T.; Machida, M.; Yoshioka, H.; Murakami, K.; Mitsuya, H. 1991: Synthesis and structure-activity relationships of 2',3'-dideoxypurine nucleosides as potential antiretroviral agents Nucleic Acids Symposium Series 25: 91-92
Perez, M.; John, G.W. 1999: Structure-activity relationships and pharmacological profiles of new 5-HT(1) receptor agonists as antimigraine agents Current Opinion in Drug Discovery and Development 2(4): 304-310
Fossa, P.; Boggia, R.; Lo Presti, E.; Mosti, L.; Dorigo, P.; Floreani, M. 1997: Inotropic Agents. Synthesis and Structure-Activity Relationships of new Milrinone Related Camp Pde Iii Inhibitors Farmaco 52(8-9): 523-530
Cellai, L.; Cerrini, S.; Segre, A.; Battistoni, C.; Cossu, G.; Mattogno, G.; Brufani, M.; Marchi, E. 1985: A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR Molecular Pharmacology 27(1): 103-108
Mailliet, P.; Segal-Bendirdjian, E.; Kozelka, J.; Barreau, M.; Baudoin, B.; Bissery, M.C.; Gontier, S.; Laoui, A.; Lavelle, F.; Le Pecq, J.B. 1995: Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships Anti-Cancer Drug Design 10(1): 51-73
Ferguson, L.R.; Baguley, B.C. 1981: Induction of petite formation in Saccharomyces cerevisiae by experimental antitumour agents. Structure--activity relationships for 9-anilinoacridines Mutation Research 90(4): 411-423
Agresti, A.; Buffoni, F.; Kaufman, J.J.; Petrongolo, C. 1980: Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water Molecular Pharmacology 18(3): 461-467
Matsumoto, F.; Nishiwaki, K.; Morita, M. 1991: Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones Nihon Rinsho. Japanese Journal of Clinical Medicine 49(10): 2291-2298
Fernández, B.; Kaumann, A.J. 1975: Structure-basicity and structure-affinity relationships of beta-adrenergic blocking agents Acta Physiologica Latino Americana 25(1): 45-51
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Cesarone, C.F.; Bolognesi, C.; Santi, L. 1980: Influence of structure and physico-chemical properties of chemical agents in the induction of DNA alterations: nitrochlorobenzenes Bollettino della Societa Italiana di Biologia Sperimentale 56(16): 1680-1686
Grammatikova, N.E.; Bibikova, M.V. 2008: Up-to-date developments for anti-HIV agents Antibiotiki i Khimioterapiia 53(3-4): 26-31
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91